About
Small Molecule for Cancer
Areas of Focus
Categories
Small Molecule PharmaceuticalMiddle East
Team (10)
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
155
By Phase
PHASE2: 1PHASE1/PHASE2: 1PHASE1: 1
By Status
COMPLETED: 2RECRUITING: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT04759664Lead Sponsor
LUT014 for the Reduction of Dose-Limiting Acneiform Lesions Associated With EGFRI Treatment of mCRC
PHASE2Recruiting
117 participants
Started: Apr 12, 2021 · Completed: May 31, 2024
NCT04261387Lead Sponsor
LUT014 for the Treatment of Radiation Induced Dermatitis in Breast Cancer Patients
PHASE1/PHASE2Completed
28 participants
Started: Jan 30, 2021 · Completed: Jul 15, 2022
NCT03876106Lead Sponsor
A Study of LUT014 in Patients With Metastatic Colorectal Cancer With EGFR Inhibitor Induced Acneiform Lesions
PHASE1Completed
10 participants
Started: Aug 21, 2019 · Completed: Nov 18, 2020
Locations (1)
Headquarters
Tel Aviv, Israel
Map
Loading map...